Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cyberonics (cybx) epilepsy therapy recommonded -- Ignore unavailable to you. Want to Upgrade?

To: Valentin who wrote (224)	3/29/1998 11:58:00 AM
From: Dennis	Read Replies (1) \| Respond to of 471

Valentin, Your analysis of cybx is very interesting, I copied it and now have it hanging in plain view so I don't forget what you said.gg If this crazy market stays intact I think you will be right. Please check out lifc again, they have MORE than one product in the pipeline. ThromboSol is going to be huge. My wife works at a Hospital, she spoke to 2 administrators about platelet preservation. There is NOTHING on the horizon other than this product. If lifc gets AABB approval this product should be HUGE. This is being funded by the U.S. Army. Go to there website at www.lifc.com There is a law suit pending involving 2 patents. So do your homework, with the good news that came out Friday, I finally bought 900 shares. This is of course my own opinion so be careful. Cybx looks like a long term winner. BTW they have a cool website too.gg